Artelo Biosciences Return on Equity

Artelo Biosciences (ARTL) currently reports a ROE of -253.57%. That is below the Consumer Staples sector average of 14.21%. Use the charts on this page to explore Artelo Biosciences's ROE history and peer comparisons.

Artelo Biosciences's ROE of -253.57% is lower than the Consumer Staples sector average of 14.21%. That is roughly 1884.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Artelo Biosciences's current -253.57% should be judged against Consumer Staples norms (sector average: 14.21%) and against ARTL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -253.57%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Staples average is 14.21%. From there, open related valuation or income-statement pages for Artelo Biosciences, and consider following ARTL for alerts when major investors trade the stock.

Artelo Biosciences is classified in the Consumer Staples sector. On ROE, it currently shows -253.57% versus a sector average near 14.21%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing ARTL with unrelated industries.